Clinical safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel factor Xa inhibitor edoxaban in healthy volunteers - Ogata, K; Mendell-Harary, J; Tachibana, M (J Clin Pharmacol, 2010)
et al.